Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing
- PMID: 29980291
- PMCID: PMC6733253
- DOI: 10.1016/j.biomaterials.2018.06.026
Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing
Abstract
Bone has well documented natural healing capacity that normally is sufficient to repair fractures and other common injuries. However, the properties of bone change throughout life, and aging is accompanied by increased incidence of bone diseases and compromised fracture healing capacity, which necessitate effective therapies capable of enhancing bone regeneration. The therapeutic potential of adult mesenchymal stem cells (MSCs) for bone repair has been long proposed and examined. Actions of MSCs may include direct differentiation to become bone cells, attraction and recruitment of other cells, or creation of a regenerative environment via production of trophic growth factors. With systemic aging, MSCs also undergo functional decline, which has been well investigated in a number of recent studies. In this review, we first describe the changes in MSCs during aging and discuss how these alterations can affect bone regeneration. We next review current research findings on bone tissue engineering, which is considered a promising and viable therapeutic solution for structural and functional restoration of bone. In particular, the importance of MSCs and bioscaffolds is highlighted. Finally, potential approaches for the prevention of MSC aging and the rejuvenation of aged MSC are discussed.
Keywords: Aging; Bone healing; MSC; Rejuvenation; Stem cell niche.
Copyright © 2018. Published by Elsevier Ltd.
Figures



References
-
- Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A, Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025, J Bone Miner Res 22(3) (2007) 465–75. - PubMed
-
- Ensrud KE, Epidemiology of fracture risk with advancing age, J Gerontol A Biol Sci Med Sci 68(10) (2013) 1236–42. - PubMed
-
- Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A, romosozumab or alendronate for fracture prevention in women with osteoporosis, N Engl J Med 377(15) (2017) 1417–1427. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical